Patel et al. and Paik et al. explained that increased breakthrough infections were associated with the use of multiple immunomodulatory therapies, such as methotrexate, mycophenolate mofetil, anti-CD20, and TNF inhibitors [105,106]. Here, TNF is linked to infection.